New Directions in Statins Research
Posted
on
Atorvastatin was the world’s best selling drug in 2006 with global revenues of over $13B. Key patents in the area ...
-
-
Cresset and Syrris Begin Strategic Partnership
Posted onSyrris has partnered with Cresset to launch MedStere to increase lead optimisation efficiency.
-
Cresset Introduces FieldStere V2.0
Posted onCresset today announced the release of a new version of its FieldStere bioisostere generator. FieldStere delivers shorter lead optimization cycles ...
-
Cresset Establishes New Versaphor Division
Posted onVersaphor offers molecular Field enabled tools to medicinal chemistry, patent, safety and in-licensing teams
-
Rational Drug Design Against GPCRs: Application to CCK2 Antagonists
Posted on -
FieldScreen 2.5.0 released
Posted on -
New Services Launched
Posted onNew Cost Efficient Lead Finding and Optimization Services Launched
-
Release of FieldStere 1.1.0
Posted onCresset announce the release of FieldStere 1.1.0 which incldues major advances in the accuracy and analysis of results
-
FieldAlign v2.1 and FieldTemplater v2.2 Released
Posted onCresset launch new versions of FieldAlign and FieldTemplater that include major enhancements in productivity and accuracy.
-
Cresset and CambridgeSoft Alliance
Posted onCresset BioMolecular Discovery Expands Sales Pipeline Potential 10 Fold through CambridgeSoft Alliance. FieldAlign and FieldTemplater Products Reach a Global Audience ...
-
Release of FieldStere
Posted onCresset announce the release of FieldStere, a revolutionary bioisostere technology.
-
Cresset and BioFocus Alliance
Posted onBioFocus DPI takes global license for Cresset’s molecular field software. “BioFocus DPI and Cresset BioMolecular Discovery announced today that BioFocus ...